Day Lucy 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 ($3.7M) Transaction Date: Mar 19, 2026 | Filing ID: 120236
Chanda Sanjay 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 ($2.9M) Transaction Date: Mar 19, 2026 | Filing ID: 120235
Director Howard Jeffrey A. 🟡 adjusted position in 73.8K shares of Atlanticus Holdings Corp (ATLC) at $54.67 Transaction Date: Mar 19, 2026 | Filing ID: 009474
Marks Gilbert Lynn 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120230
Aziz Kabeer 🟡 adjusted position in 0 shares (4 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120226
Martin Patricia A. 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120223
FitzPatrick Margaret M 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $18.24 Transaction Date: Mar 19, 2026 | Filing ID: 120221
Wong Stephanie 🟡 adjusted position in 0 shares (6 derivative) of AN2 Therapeutics, Inc. (ANTX) at $17.28 Transaction Date: Mar 19, 2026 | Filing ID: 120216